Amandine Caillaud

Nantes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

LDLR-3'UTR Deletions Identified as a Genetic Cause of Hypobetalipoproteinemia: Evidence From Familial and Population-Based Studies.

LDLR-3'UTR Deletions Identified as a Genetic Cause of Hypobetalipoproteinemia: Evidence From Familial and Population-Based Studies.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 04, 2026

Biological maturation drives the hepatic-to-renal switch in erythropoietin production at birth.

Biological maturation drives the hepatic-to-renal switch in erythropoietin production at birth.

Journal: EBioMedicine

Published: September 11, 2025

Identification of Hepatic-like EPO as a Cause of Polycythemia.

Identification of Hepatic-like EPO as a Cause of Polycythemia.

Journal: The New England journal of medicine

Published: April 30, 2025

Human induced pluripotent stem cells-derived liver organoids grown on a Biomimesys® hyaluronic acid-based hydroscaffold as a new model for studying human lipoprotein metabolism.

Human induced pluripotent stem cells-derived liver organoids grown on a Biomimesys® hyaluronic acid-based hydroscaffold as a new model for studying human lipoprotein metabolism.

Journal: Bioengineering & translational medicine

Published: July 27, 2023

Generation of an induced pluripotent stem cell line (ITXi012-A) from a patient with genetically determined high-lipoprotein(a) plasma levels.

Generation of an induced pluripotent stem cell line (ITXi012-A) from a patient with genetically determined high-lipoprotein(a) plasma levels.

Journal: Stem cell research

Published: April 17, 2023

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis.

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis.

Journal: Haematologica

Published: February 10, 2023

Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile.

Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: September 01, 2022

Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia.

Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia.

Journal: Circulation

Published: July 28, 2022

FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.

FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.

Journal: STAR protocols

Published: March 22, 2022

APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants.

APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants.

Journal: International journal of molecular sciences

Published: February 13, 2022

Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1).

Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1).

Journal: Stem cell research

Published: December 13, 2021

Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system.

Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system.

Journal: Stem cell research

Published: November 26, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026